EnviroTech :: Biotech
Bayer Acquires Biotech Company
10:48 AM MDT | September 22, 2008 | Chemical Week Editorial Staff
Bayer HealthCare says it has acquired biotechnology company Direvo Biotech (Cologne) for €210 million ($298 million). Direvo specializes in protein engineering and “strengthens the research competence in biologics of the pharmaceuticals division Bayer Schering Pharma,” Bayer HealthCare says. The deal is scheduled to close at the end of this month. Bayer HealthCare plans to integrate Direvo’s R&D personnel into Bayer Schering Pharma’s drug discovery organization. Separately, Bayer’s share price rose again last week on...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee